Workshop: Contemporary genomic studies in hematologic pathology: Utility of next generation sequencing in clinical evaluation of myeloid and lymphoid malignancies. Presented by Bevan Tandon M.D. Hematopathologist and Laboratory Director Molecular Diagnostics and Genomic Solutions.
Short Course 18: NEXT GENERATION SEQUENCING AS A DIAGNOSTICS PLATFORM.
Jamie L. Platt, PhD. Vice President, Genomic Solutions. Advanced sequencing technologies are highly dependent on bioinformatics tools and appropriate interpretation. In addition to applying the optimized bioinformatic algorithms with specific, validated thresholds, transforming the data into clinically useful information requires appropriate annotation. The application typically dictates the knowledge base of choice as well as the clinical interpretation. Selecting or building the appropriate bioinformatics, annotation solutions and clinical interpretation are challenges for commercial clinical labs that will be discussed within the context of Genomics, Genetics, and RNA-Seq.
Tues March 8th 5:00pm. Discussion Group on NGS Assay Development and Validation led by Jamie L. Platt, PhD. Vice President, Genomic Solutions. Jamie will discuss NGS clinical test requirements – panels vs exomes/genomes; Development and validation of germline clinical NGS tests; Development and validation of somatic clinical NGS tests.
Clinical Diagnostics Development, NGS and Genomic Markers. Chairperson for stream Jamie Platt, PhD. Vice President Genomic Solutions.
Beyond Technology: Bridging Genomics Gaps to Drive Paradigm Shifts in Clinical Research and Reference Laboratories. Presented by Jamie Platt, Ph.D. Vice President Genomic Solutions. Register for event with ThermoFIsher
Clinical Trial Services in the Molecular Diagnostics Laboratory: A Blended Business Model for Revenue Diversification. Presented by Nicholas T. Potter, PhD. FACMG, Executive Vice President of Clinical Affairs. Molecular testing has been the most rapidly growing segment of the laboratory industry for nearly a decade, yet achieving profitability for these high-cost, high-value tests remains a challenge. Learn how your laboratory can make the most of molecular diagnostics and the evolving technologies of genomic medicine through an in-depth look at a partnership model pioneered by Molecular Pathology Laboratory Network. This case study will discuss the opportunities for laboratories to take on clinical trial work and the role of this contract work in diversifying revenue and providing financial stability
Bridging the Gaps in Precision Medicine through NGS in Pharma and Clinical Diagnostics. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
Advancing Pathology and Cancer Research with NGS. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
San Diego Sep 18th 2015
Philadelphia Sep 15th 2015
University of Tennessee Health Science Center Memphis TN. Sep 10th. Targeted Gene Panels for Oncology Research. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
Atlanta GA. Sep 17th. Targeted Gene Panels for Oncology Research. Presented by Jamie Platt, PhD.
AUG 17th. 2:00pm. Short Course (SC7). NGS AS A DIAGNOSTICS PLATFORM. Part One: How Multi-Gene Panel and Exome Testing are Becoming New Diagnostic Standards for Inherited Disorders. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
AUG 20th.7:30 am. Problem-Solving Breakout Discussions. NGS Annotation and Interpretation: Practical Approaches. Presented by Jamie Platt, Ph.D. Vice President Genomic Solutions.
AUG 20th 2:00pm. NGS ANNOTATION IN GENOMICS, GENETICS, AND RNA-SEQ. The NGS Annotation Landscape for Genomics, Genetics, and RNA-Seq: Current Challenges for Commercial Clinical Labs. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
New User Experience: Validating the RainDrop and ThunderBolts Systems. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
From LDTs to NGS IVD Systems, A Customer’s Perspective. Presented by Jamie Platt, PhD. Vice President Genomic Solutions.
Opportunities and Challenges for NGS-Based Clinical Trials. Jamie L. Platt, PhD. Vice President, Genomic Solutions, Geneuity (an MPLN company)
Global Innovation and Marketing in NGS. Panelist. Jamie L. Platt, PhD. Vice President, Genomic Solution
Biospecimen Science and Sample Prep. NGS-Based Clinical Assays: Building Castles in the Air. Jamie L. Platt, PhD.
FDA-Approved Versus LDT-Based NGS Systems: Preanalytical Issues and Validation. Jamie L. Platt, PhD.
PANEL DISCUSSION: Comparing Major NGS Instruments: Technical Differences, Application Preferences
Clinical Next-Generation Sequencing in the CLIA Environment: Mythos and Logos in Today’s Molecular Labs . Jamie L. Platt, PhD. CGMBS, MB(ASCP), Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.